
Pentastar 40mg Injection
Marketer
Adcock Ingram Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pentastar 40mg Injection
Gastric acid secretion is suppressed by the intravenous administration of 40mg Acidaze Injection. This medication treats stomach and intestinal conditions stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and facilitating healing. Acidaze 40mg Injection also prevents stress ulcers in critically ill patients and is prophylactically administered before anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable medication is solely administered intravenously by a medical professional when deemed more appropriate than oral administration. Dosage is individualized based on patient response and underlying condition; treatment duration, determined by your physician, should be strictly followed even with rapid symptom resolution. Optimal treatment efficacy is enhanced by frequent, smaller meals and avoidance of caffeinated beverages, spicy, and fatty foods. Common, generally mild side effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant immediate medical attention. Prolonged use, especially exceeding one year, may increase the risk of bone fractures, particularly at higher doses; discuss bone health maintenance, such as calcium and vitamin D supplementation, with your doctor. Acidaze 40mg Injection is contraindicated in individuals with severe hepatic impairment, those on HIV medication, those with a history of similar medication allergies, or pre-existing osteoporosis. Pregnant or lactating individuals must consult their physician before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Uses of Pentastar 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pentastar 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pentastar 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pentastar 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pentastar 40mg Injection works:
Acid reflux and indigestion find relief with the proton pump inhibitor (PPI), Pentastar 40mg Injection. This medication lessens stomach acid production, thus alleviating symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pentastar 40mg Injection with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Pentastar 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Pentastar 40mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pentastar 40mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pentastar 40mg Injection presents no need for dosage modification in patients with renal impairment and is considered safe for their use.
LiverCAUTION
For individuals with severe hepatic impairment, administering Pentastar 40mg Injection requires careful consideration. Dosage modification of Pentastar 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Pentastar 40mg Injection :
Omit a Pentastar 40mg Injection? Seek your physician's advice.
Facts to Know About Pentastar 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfoxide compound |
| Addictive | None. |
| Medication Classification | Digestive system |
| Mechanism of Action | Gastric acid secretion blockers |
